סנדאימון   ניאורל   100 מג כמוסות ישראל - עברית - Ministry of Health

סנדאימון ניאורל 100 מג כמוסות

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 100 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

רבלימיד 5 מ"ג ישראל - עברית - Ministry of Health

רבלימיד 5 מ"ג

neopharm scientific ltd - lenalidomide 5 mg - capsules - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

רבלימיד 10 מ"ג ישראל - עברית - Ministry of Health

רבלימיד 10 מ"ג

neopharm scientific ltd - lenalidomide 10 mg - capsules - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

רבלימיד 15 מ"ג ישראל - עברית - Ministry of Health

רבלימיד 15 מ"ג

neopharm scientific ltd - lenalidomide 15 mg - capsules - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

רבלימיד 25 מ"ג ישראל - עברית - Ministry of Health

רבלימיד 25 מ"ג

neopharm scientific ltd - lenalidomide 25 mg - capsules - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

אקסלון   1.5 מג ישראל - עברית - Ministry of Health

אקסלון 1.5 מג

novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 1.5 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

אקסלון   3 מג ישראל - עברית - Ministry of Health

אקסלון 3 מג

novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 3 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

אקסלון   4.5 מג ישראל - עברית - Ministry of Health

אקסלון 4.5 מג

novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 4.5 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementiasymptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

אקסלון   6 מג ישראל - עברית - Ministry of Health

אקסלון 6 מג

novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 6 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

פוסיטלמיק וטרינרי ישראל - עברית - Ministry of Health

פוסיטלמיק וטרינרי

vetmarket marketing ltd - fusidic acid as hemihydrate 1 % - eye drops - for the topical treatment of conjunctivitis in the dogs and cats associated with staphylococcus aureus and in particular the biotype staphylococcus intermedius. for the topical treatment of conjunctivitis in the dogs and cats associated with secondary staphylococcal infections.